Fundeni Clinical Institute — Bucharest

What best describes you?

🧭 Patient, caregiver or referring clinician

This page counts public registry records — it is not a list of trials you can join.

Studies recruiting near Bucharest →

Never medical advice — always discuss trial participation with your own doctor first.

🏢 I work at this facility, a sponsor or a CRO

Verify and correct how this facility appears in public registry records — free — and open the full registry-entry list below.

Verify this profile →

Public research footprint of Fundeni Clinical Institute, compiled from the ClinicalTrials.gov public registry.

114

Registered studies

43

Active

22

Recruiting now

60

Completed

7

Stopped or withdrawn

Most-studied conditions

Relapsed or Refractory Multiple Myeloma (RRMM) · Untreated, Unresectable, or Metastatic Colorectal Cancer · End Stage Kidney Disease (ESRD) · Acute Myeloid Leukemia, in Relapse

Recently updated registry entries

NCT03105102 — A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease (Active Not Recruiting)
NCT06997497 — A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People… (Recruiting)
NCT06430801 — A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants… (Recruiting)

7 more recent registry entries at this facility

Research staff — enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Compiled from public registry records (ClinicalTrials.gov) as of August 08, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.